Condensed Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands	Total	Total Stockholders’ Equity attributable to Privia Health Group, Inc.	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Non-controlling Interest
Beginning balance (in shares) at Dec. 31, 2021			107,837,741
Beginning balance at Dec. 31, 2021	$ 450,181	$ 426,872	$ 1,078	$ 633,902	$ (208,108)	$ 23,309
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)			435,030
Issuance of common stock upon exercise of stock options	799	799	$ 5	794
Stock-based compensation expense	24,881	24,881		24,881
Contributed non-controlling interest	125					125
Net (loss) income	(18,087)	(17,510)			(17,510)	(577)
Ending balance (in shares) at Mar. 31, 2022			108,272,771
Ending balance at Mar. 31, 2022	$ 457,899	435,042	$ 1,083	659,577	(225,618)	22,857
Beginning balance (in shares) at Dec. 31, 2022	114,690,808		114,690,808
Beginning balance at Dec. 31, 2022	$ 519,049	499,094	$ 1,148	714,639	(216,693)	19,955
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)			779,153
Issuance of common stock upon exercise of stock options	1,477	1,477	$ 11	1,466
Stock-based compensation expense	5,381	5,381		5,381
Contributed non-controlling interest	24,212					24,212
Net (loss) income	$ 6,402	7,324			7,324	(922)
Ending balance (in shares) at Mar. 31, 2023	115,469,961		115,469,961
Ending balance at Mar. 31, 2023	$ 556,521	$ 513,276	$ 1,159	$ 721,486	$ (209,369)	$ 43,245